检索结果 - Azher Hussain
- Showing 1 - 2 results of 2
-
1
-
2
Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough 由 David Muccino, Alyn H. Morice, Surinder S. Birring, Peter V. Dicpinigaitis, Ian Pavord, Christopher Assaid, Huub Jan Kleijn, Azher Hussain, Carmen La Rosa, Lorcan McGarvey, John A. Smith
出版 2020Artigo
相关主题
Adverse effect
Alternative medicine
Anesthesia
Antibody
Asthma
Astrobiology
Biochemistry
Biodistribution
Biology
Chemistry
Chronic cough
Clinical trial
Immunoglobulin G
Immunology
In vitro
Internal medicine
Medicine
Molecular biology
Neonatal Fc receptor
Pathology
Physics
Placebo
Randomized controlled trial
Receptor
Refractory (planetary science)
Spleen
Tolerability